Larry Biegelsen
Stock Analyst at Wells Fargo
(4.29)
# 495
Out of 4,413 analysts
204
Total ratings
59.38%
Success rate
11.43%
Average return
Main Sectors:
32 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Overweight | $103 → $110 | $102.52 | +7.30% | 8 | May 2, 2024 | |
| SYK Stryker | Maintains: Overweight | $364 → $381 | $324.89 | +17.27% | 9 | May 1, 2024 | |
| NARI Inari Medical | Maintains: Overweight | $100 → $84 | $42.23 | +98.91% | 3 | May 1, 2024 | |
| EW Edwards Lifesciences | Maintains: Overweight | $94 → $99 | $84.57 | +17.06% | 12 | Apr 26, 2024 | |
| BSX Boston Scientific | Maintains: Overweight | $72 → $82 | $71.45 | +14.77% | 5 | Apr 25, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $17 → $14 | $10.48 | +33.59% | 7 | Apr 8, 2024 | |
| NVCR NovoCure | Maintains: Overweight | $49 → $42 | $12.51 | +235.73% | 15 | Apr 3, 2024 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $2.1 → $1.6 | $0.83 | +93.00% | 3 | Mar 22, 2024 | |
| LUNG Pulmonx | Downgrades: Equal-Weight | $16 → $14 | $9.42 | +48.62% | 4 | Feb 23, 2024 | |
| BLCO Bausch + Lomb | Maintains: Overweight | $21 → $23 | $13.51 | +70.24% | 2 | Feb 22, 2024 | |
| SWAV ShockWave Medical | Maintains: Equal-Weight | $200 → $210 | $329.69 | -36.30% | 6 | Feb 16, 2024 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $363 → $416 | $371.00 | +12.13% | 13 | Jan 19, 2024 | |
| AXNX Axonics | Downgrades: Equal-Weight | $68 → $71 | $66.87 | +6.18% | 4 | Jan 10, 2024 | |
| DXCM DexCom | Maintains: Overweight | $110 → $136 | $125.25 | +8.58% | 6 | Dec 13, 2023 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $187 | $243.40 | -23.17% | 4 | Dec 13, 2023 | |
| JNJ Johnson & Johnson | Downgrades: Equal-Weight | $170 → $163 | $150.00 | +8.67% | 9 | Dec 13, 2023 | |
| RXST RxSight | Upgrades: Overweight | $42 | $57.74 | -27.25% | 5 | Dec 13, 2023 | |
| IART Integra LifeSciences Holdings | Upgrades: Overweight | $40 → $49 | $29.00 | +68.99% | 2 | Dec 5, 2023 | |
| MDT Medtronic | Maintains: Overweight | $100 → $102 | $80.41 | +26.86% | 11 | Aug 23, 2023 | |
| ALC Alcon | Maintains: Overweight | $80 → $89 | $78.07 | +14.01% | 4 | Aug 17, 2023 | |
| GEHC GE HealthCare Technologies | Initiates: Overweight | $90 | $78.11 | +15.22% | 1 | Aug 16, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $40 → $30 | $35.54 | -15.59% | 4 | Aug 4, 2023 | |
| TFX Teleflex | Maintains: Equal-Weight | $241 → $236 | $205.10 | +15.07% | 3 | Aug 4, 2023 | |
| PEN Penumbra | Maintains: Overweight | $320 → $337 | $204.44 | +64.84% | 9 | Aug 2, 2023 | |
| BAX Baxter International | Maintains: Equal-Weight | $46 → $44 | $37.62 | +16.97% | 7 | Jul 28, 2023 | |
| COO The Cooper Companies | Maintains: Overweight | $89 → $108 | $88.50 | +21.47% | 13 | May 15, 2023 | |
| MMSI Merit Medical Systems | Maintains: Equal-Weight | $74 → $81 | $76.58 | +5.78% | 4 | Apr 27, 2023 | |
| ABT Abbott Laboratories | Maintains: Overweight | $140 → $136 | $105.67 | +28.70% | 18 | Apr 5, 2023 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Equal-Weight | $116 → $124 | $120.78 | +2.67% | 5 | Nov 23, 2022 | |
| GMED Globus Medical | Maintains: Overweight | $80 → $70 | $50.34 | +39.05% | 4 | May 11, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | n/a | $236.00 | - | 3 | Apr 8, 2020 | |
| LNTH Lantheus Holdings | Upgrades: Outperform | n/a | $77.55 | - | 1 | Nov 2, 2017 |
Glaukos
May 2, 2024
Maintains: Overweight
Price Target: $103 → $110
Current: $102.52
Upside: +7.30%
Stryker
May 1, 2024
Maintains: Overweight
Price Target: $364 → $381
Current: $324.89
Upside: +17.27%
Inari Medical
May 1, 2024
Maintains: Overweight
Price Target: $100 → $84
Current: $42.23
Upside: +98.91%
Edwards Lifesciences
Apr 26, 2024
Maintains: Overweight
Price Target: $94 → $99
Current: $84.57
Upside: +17.06%
Boston Scientific
Apr 25, 2024
Maintains: Overweight
Price Target: $72 → $82
Current: $71.45
Upside: +14.77%
Nevro
Apr 8, 2024
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $10.48
Upside: +33.59%
NovoCure
Apr 3, 2024
Maintains: Overweight
Price Target: $49 → $42
Current: $12.51
Upside: +235.73%
Hyperfine
Mar 22, 2024
Maintains: Equal-Weight
Price Target: $2.1 → $1.6
Current: $0.83
Upside: +93.00%
Pulmonx
Feb 23, 2024
Downgrades: Equal-Weight
Price Target: $16 → $14
Current: $9.42
Upside: +48.62%
Bausch + Lomb
Feb 22, 2024
Maintains: Overweight
Price Target: $21 → $23
Current: $13.51
Upside: +70.24%
ShockWave Medical
Feb 16, 2024
Maintains: Equal-Weight
Price Target: $200 → $210
Current: $329.69
Upside: -36.30%
Intuitive Surgical
Jan 19, 2024
Maintains: Overweight
Price Target: $363 → $416
Current: $371.00
Upside: +12.13%
Axonics
Jan 10, 2024
Downgrades: Equal-Weight
Price Target: $68 → $71
Current: $66.87
Upside: +6.18%
DexCom
Dec 13, 2023
Maintains: Overweight
Price Target: $110 → $136
Current: $125.25
Upside: +8.58%
Inspire Medical Systems
Dec 13, 2023
Downgrades: Equal-Weight
Price Target: $187
Current: $243.40
Upside: -23.17%
Johnson & Johnson
Dec 13, 2023
Downgrades: Equal-Weight
Price Target: $170 → $163
Current: $150.00
Upside: +8.67%
RxSight
Dec 13, 2023
Upgrades: Overweight
Price Target: $42
Current: $57.74
Upside: -27.25%
Integra LifeSciences Holdings
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $29.00
Upside: +68.99%
Medtronic
Aug 23, 2023
Maintains: Overweight
Price Target: $100 → $102
Current: $80.41
Upside: +26.86%
Alcon
Aug 17, 2023
Maintains: Overweight
Price Target: $80 → $89
Current: $78.07
Upside: +14.01%
GE HealthCare Technologies
Aug 16, 2023
Initiates: Overweight
Price Target: $90
Current: $78.11
Upside: +15.22%
Tandem Diabetes Care
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $40 → $30
Current: $35.54
Upside: -15.59%
Teleflex
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $241 → $236
Current: $205.10
Upside: +15.07%
Penumbra
Aug 2, 2023
Maintains: Overweight
Price Target: $320 → $337
Current: $204.44
Upside: +64.84%
Baxter International
Jul 28, 2023
Maintains: Equal-Weight
Price Target: $46 → $44
Current: $37.62
Upside: +16.97%
The Cooper Companies
May 15, 2023
Maintains: Overweight
Price Target: $89 → $108
Current: $88.50
Upside: +21.47%
Merit Medical Systems
Apr 27, 2023
Maintains: Equal-Weight
Price Target: $74 → $81
Current: $76.58
Upside: +5.78%
Abbott Laboratories
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $105.67
Upside: +28.70%
Zimmer Biomet Holdings
Nov 23, 2022
Upgrades: Equal-Weight
Price Target: $116 → $124
Current: $120.78
Upside: +2.67%
Globus Medical
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $50.34
Upside: +39.05%
Becton, Dickinson and Company
Apr 8, 2020
Maintains: Overweight
Price Target: n/a
Current: $236.00
Upside: -
Lantheus Holdings
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $77.55
Upside: -